Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02716441 · ClinicalTrials.gov registry record
Rotator Cuff Failure With Continuity
A clinical trial of Rotator Cuff Tear, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 125
- Enrollment target
- 1
- Study location
NCT02716441: Active study of Rotator Cuff Tear, sponsored by The Cleveland Clinic.
NCT02716441 is a study of Rotator Cuff Tear that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 125 participants, above the 82-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02716441, a study of Rotator Cuff Tear, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal's objective is to challenge and expand the current definition of rotator cuff healing by investigating tendon retraction - broadly defined as medial translation of the repaired tendon away from the bone with or without a defect - as a common and clinically predictive structural outcome following rotator cuff repair. The investigators' central hypothesis is that failure with continuity is a common yet unrecognized structural phenomenon of rotator cuff healing that is significantly and meaningfully correlated with clinical outcomes. The investigators' approach is to characterize tendon retraction using an array of implanted radio-opaque markers, and investigate its relationship to pre-operative tissue quality (MRI), post-operative repair structural integrity (MRI) and clinical outcomes in a 125-patient prospective cohort study. These patients will complete (1) validated questionnaires and range of motion testing pre-operatively, (2) CT imaging at day of surgery, 3 weeks, 3 and 6 months, and 1, 2 and 5 years post-operatively, (3) MRI at 3 weeks, 3 and 6 months, and 1, 2 and 5 years post-operatively and (4) questionnaires, range of motion and strength testing at 3 and 6 months and 1, 2 and 5 years post-operatively.
Primary Outcome
Medial translation of the repaired tendon away from the bone between the day of surgery and 1, 2 and 5 years following rotator cuff repair as measured by CT imaging of radio-opaque markers implanted on the tendon.
Conditions Studied
Interventions
- DEVICE Radio-opaque Tissue Markers
Study Locations (1)
Ohio
- Cleveland Clinic Main Campus - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2016-09 |
| Est. Completion | 2026-04 |
What the registry record for NCT02716441 still lists
NCT02716441 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, above the 82-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (52% higher).
The record links to 1 condition, with Rotator Cuff Tear appearing as the primary indexed condition, and to 1 intervention - of which Radio-opaque Tissue Markers is the first listed.
NCT02716441 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02716441 about?
NCT02716441 is a clinical study titled "Rotator Cuff Failure With Continuity". This proposal's objective is to challenge and expand the current definition of rotator cuff healing by investigating tendon retraction - broadly defined as medial translation of the repaired tendon away from the bone with or without a defect - as a common and clinically predictive structural outcome...
What is the current status of trial NCT02716441?
This trial is currently active not recruiting. The enrollment target is 125 participants. The study started on 2016-09. Estimated completion is 2026-04.
What conditions does trial NCT02716441 study?
This clinical trial studies the following conditions: Rotator Cuff Tear.
What interventions are being tested in trial NCT02716441?
The interventions under investigation include: Radio-opaque Tissue Markers (DEVICE).
Who is sponsoring clinical trial NCT02716441?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02716441 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02716441's enrollment target sits among peer trials
125 2nd of 11 the highest of 11 other Rotator Cuff Tear trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rotator Cuff Tear trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
Oxandrolone Rotator Cuff Trial
ACTIVE NOT RECRUITING · NA
-
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
ACTIVE NOT RECRUITING · NA
-
Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears
ACTIVE NOT RECRUITING · Phase 2
-
Opioid-Free Shoulder Arthroplasty
COMPLETED · Phase 4
-
Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia